Avantor: Enhancing Lab Efficiency in US Biotech Hubs (Boston & San Francisco)
In the volatile landscape of life sciences equities, insider activity often serves as a lighthouse for investors navigating turbulent waters. The latest signal comes from Avantor, Inc. (NYSE: AVTR), where a notable purchase by a company director has emerged as a point of interest for market analysts tracking the biotechnology supply chain. Recent filings reveal … Read more